Left Main-to-LAD Crossover Versus Focal Ostial Stenting for Isolated Medina 0,1,0 Ostial LAD Stenosis: A Retrospective Comparative Cohort Study
Pakistan Heart Journal · 04.10.2026 · 59 (5) · 1547-1558
DOI: 10.47144/phj.v59i5.3951 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pakistan Heart Journal, online erschienen am 04.10.2026. Verfasst von Rafi Ullah und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To compare 12-month clinical and procedural outcomes associated with left main coronary artery (LMCA)-to-left anterior descending artery (LAD) crossover stenting (COS) versus focal ostial-only stenting (OS) in patients undergoing percutaneous coronary intervention (PCI) for isolated true ostial LAD lesions with Medina 0,1,0 anatomy. Methodology: This single-center retrospective observational cohort study included 275 consecutive patients undergoing PCI for isolated ostial LAD stenosis between January 2021 and December 2024. Patients were treated with either LMCA-to-LAD crossover stenting (COS; n=111) or focal ostial-only stenting (OS; n=164), according to operator judgment and anatomical considerations. The primary 12-month composite outcome was target lesion failure, comprising cardiac death, target-vessel myocardial infarction, and clinically driven target lesion revascularization.
Results
At 12 months, the primary composite adverse outcome occurred in 7.2% (8/111) of patients undergoing COS compared with 16.5% (27/164) undergoing OS (OR 2.54, 95% CI 1.11–5.82; p=0.027). The association remained after penalized multivariable adjustment (aOR 2.17, bootstrap 95% CI 1.14–4.35; p=0.019) and propensity-score IPTW (OR 2.58, 95% CI 1.14–5.84; p=0.023). The ischemic MACE sensitivity endpoint occurred in 2.7% versus 14.0% of patients, respectively (OR 5.87, 95% CI 1.72–20.07; p=0.001). Acute side-branch compromise occurred more frequently with COS (12.6% vs. 5.5%; p=0.046), although bailout side-branch stenting was uncommon in both groups (1.8% vs. 1.2%; p=1.000). All-cause mortality did not differ significantly between groups (4.5% vs. 10.4%; OR 2.45, 95% CI 0.88–6.85; p=0.111). These values correspond to the outcome data reported in the revised manuscript.
Conclusion
Among patients with isolated Medina 0,1,0 ostial LAD disease, LMCA-to-LAD crossover stenting was associated with fewer 12-month composite adverse events than focal ostial-only stenting after adjustment for measured confounders. Crossover stenting was associated with a higher frequency of acute side-branch compromise, although bailout side-branch stenting remained uncommon, and no statistically significant difference in all-cause mortality was observed. Given the retrospective, non-randomized design, these findings demonstrate associations rather than causal superiority and warrant confirmation in prospective multicenter studies.
Zitieren
APA
Ullah, R., Waleed, M., Wadood, A. U., Khattak, S. N., Raza, A., & Ullah, S. (2026). Left Main-to-LAD Crossover Versus Focal Ostial Stenting for Isolated Medina 0,1,0 Ostial LAD Stenosis: A Retrospective Comparative Cohort Study. Pakistan Heart Journal, 59(5), 1547-1558. https://doi.org/10.47144/phj.v59i5.3951
Vancouver
Ullah R, Waleed M, Wadood AU, Khattak SN, Raza A, Ullah S. Left Main-to-LAD Crossover Versus Focal Ostial Stenting for Isolated Medina 0,1,0 Ostial LAD Stenosis: A Retrospective Comparative Cohort Study. Pakistan Heart Journal. 2026;59(5):1547-1558. doi:10.47144/phj.v59i5.3951
BibTeX
@article{Ullah2026,
author = {Ullah, Rafi and Waleed, Muhammad and Wadood, Atta Ul and Khattak, Seema Nazeer and Raza, Ali and Ullah, Shafi},
title = {Left Main-to-LAD Crossover Versus Focal Ostial Stenting for Isolated Medina 0,1,0 Ostial LAD Stenosis: A Retrospective Comparative Cohort Study},
journal = {Pakistan Heart Journal},
year = {2026},
volume = {59},
number = {5},
pages = {1547--1558},
doi = {10.47144/phj.v59i5.3951}
}
EUVIMED